Effects of Concomitant Administration of PXR Ligand Drugs on the Anticoagulant Effects of Warfarin.

Mito, Ayane; Hirono, Keiichi; Ide, Haruka; Ozawa, Sayaka; Ichida, Fukiko; Taguchi, Masato

Mito, Ayane; Hirono, Keiichi; Ide, Haruka; Ozawa, Sayaka; Ichida, Fukiko; Taguchi, Masato.

Afiliação

Mito A; Department of Pharmacy Practice and Sciences, School of Pharmacy and Pharmaceutical Sciences, University of Toyama.
Hirono K; Department of Pediatrics, Faculty of Medicine, University of Toyama.
Ide H; Department of Pharmacy Practice and Sciences, School of Pharmacy and Pharmaceutical Sciences, University of Toyama.
Ozawa S; Department of Pediatrics, Faculty of Medicine, University of Toyama.
Ichida F; Department of Pediatrics, International University of Health and Welfare.
Taguchi M; Department of Pharmacy Practice and Sciences, School of Pharmacy and Pharmaceutical Sciences, University of Toyama.

Biol Pharm Bull ; 45(6): 703-708, 2022 Jun 01.

Article em En | MEDLINE | ID: mdl-35370222

Assuntos

Rifampina; Varfarina; Anticoagulantes/farmacologia; Anticoagulantes/uso terapêutico; Bosentana; Criança; Pré-Escolar; Feminino; Humanos; Coeficiente Internacional Normatizado; Ligantes; Estudos Longitudinais; Preparações Farmacêuticas; Receptor de Pregnano X; Rifampina/farmacologia; Rifampina/uso terapêutico; Varfarina/farmacologia; Varfarina/uso terapêutico

Palavras-chave

bosentan; drug interaction; macitentan; pregnane X receptor; warfarin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Rifampina / Varfarina Tipo de estudo: Observational_studies Limite: Child / Child, preschool / Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google